Global Cancer Profiling Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Technology, Technique, Application & Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Industry Forecast (2022 to 2027)

8871.84
Present Value (M$)
2021
21260
Forecast Value (M$)
2027
15.68%
CAGR (%)

he global cancer profiling market size is estimated to value USD 21.26 Billion by the end of 2027, growing at a remarkable CAGR of more than 15.68% FROM 2022 to 2027. COVID-19 impact on this market is included in this report.

Main companies

  • Illumina
  • Inc. (US)
  • QIAGEN N.V. (Germany)
  • NeoGenomics Laboratories
  • Inc. (U.S.)
  • HTG Molecular Diagnostics
  • Inc. (U.S.)
  • Genomic Health Inc. (U.S.)
  • Caris Life Sciences (U.S.)
  • Helomics Corporation (U.S.)
  • NanoString Technologies
  • Inc. (U.S.)
  • Sysmex Corporation (Japan)
  • RiboMed Biotechnologies
  • Inc. (U.S.)
  • Guardant Health
  • Inc. (U.S.)
  • Foundation Medicine (U.S.)